Pharmaceutical Executive
The three leading justifications for sticker-shocking drug prices in the US.
Ben Comer
Advertisement
Articles by Ben Comer
Advertisement
Latest Updated Articles
Paying for the Future of MedicineMay 20th 2014
Advertisement
Advertisement
Trending on PharmExec
1
Aradhana Sarin: The CFO as a Catalyst
2
Regeneron Enters $2.1 Billion Radiopharma Collaboration with Telix Pharmaceuticals
3
Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment
4
Managing Patient Experience and RWE in Clinical Trials: Q&A with Matt Holms, MB
5